Cargando…
Arterial Blood, Rather Than Venous Blood, is a Better Source for Circulating Melanoma Cells
BACKGROUND: CTCs provide prognostic information and their application is under investigation in multiple tumor types. Of the multiple variables inherent in any such process, none is more important to outcome than the appropriateness of the sample source. To address this question, we investigated CTC...
Autores principales: | Terai, Mizue, Mu, Zhaomei, Eschelman, David J., Gonsalves, Carin F., Kageyama, Ken, Chervoneva, Inna, Orloff, Marlana, Weight, Ryan, Mastrangelo, Michael J., Cristofanilli, Massimo, Sato, Takami |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740300/ https://www.ncbi.nlm.nih.gov/pubmed/26870807 http://dx.doi.org/10.1016/j.ebiom.2015.09.019 |
Ejemplares similares
-
An Outcome Assessment of a Single Institution’s Longitudinal Experience with Uveal Melanoma Patients with Liver Metastasis
por: Seedor, Rino S., et al.
Publicado: (2020) -
Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2021) -
Expression of Tryptophan 2,3-Dioxygenase in Metastatic Uveal Melanoma
por: Terai, Mizue, et al.
Publicado: (2020) -
Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Seedor, Rino S., et al.
Publicado: (2021) -
A Pilot Study of Hepatic Irradiation with Yttrium-90 Microspheres Followed by Immunotherapy with Ipilimumab and Nivolumab for Metastatic Uveal Melanoma
por: Minor, David R., et al.
Publicado: (2022)